James T Symanowski
8PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 11, 2026
ToPCourT protocol: a phase II trial of Trilaciclib, Pembrolizumab, gemcitabine, and Carboplatin in locally advanced/unresectable or metastatic Triple-negative breast cancer.Megan B Sears-Smith, Ashley Matusz-Fisher, James T Symanowski
|Sep 29, 2025
Re-Evaluating Established Prognostic Models in the Era of Immunotherapy in Renal Cell Carcinoma.Claud M Grigg, James Symanowski
|Mar 07, 2025
Abstract Thinking and Statins With Immune Checkpoint Inhibitors: Enough to Change Clinical Practice?Derek Raghavan, James Symanowski
|Jan 31, 2025
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers.Arielle L Heeke, Andrew Elliott, Kaitlyn O'Keefe
|Nov 18, 2024
Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical Practice.Nilanjan Ghosh, Ashley Matusz-Fisher, Rupali Bose
|Jun 27, 2024
Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center.D Grace Nguyen, Sarah A Morris, Alicia Hamilton
Pageof 2
Frequent Collaborators
3 joint publications
Derek Raghavan
2 joint publications
Antoinette R Tan
1 joint publications
Thomas G Knight
1 joint publications
Melissa Aguiar
1 joint publications
Myra Robinson
1 joint publications
Brittany K Ragon
1 joint publications
Aleksander L Chojecki
1 joint publications
Carol J Farhangfar
1 joint publications
Ashley Matusz-Fisher
1 joint publications
Victoria A Morris
